Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling
Yuanyuan Zhai, Wenling Zhou, Xu Yan, et al.
Phytomedicine (2022) Vol. 107, pp. 154444-154444
Closed Access | Times Cited: 25

Showing 25 citing articles:

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
Linsen Shi, Lihua Jin, Wendong Huang
Cells (2023) Vol. 12, Iss. 14, pp. 1888-1888
Open Access | Times Cited: 39
Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis
Yuan Li, Gaihe Chen, Xiaohuan Hu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
Tianqi Cai, Xinhua Song, Xiaoxue Xu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Ameliorative Effect of Glycyrrhizic Acid on Diosbulbin B-Induced Liver Injury and Its Mechanism
Xin Wang, Lubing Shi, Yu-Han Zhang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-27
Closed Access
Multiomics combined analysis reveals protective effect of 7-O-α-L-rhamnopyranosyl-kaempferol-3-O-β-D-glucopyranoside on autoimmune hepatitis
Wei Xiao, Zhiqiang Li, Yilei Wang, et al.
Phytomedicine (2025) Vol. 139, pp. 156460-156460
Closed Access
Sanye Tablet regulates gut microbiota and bile acid metabolism to attenuate hepatic steatosis
Yulin Qi, Siqi Du, Wenwen Li, et al.
Journal of Ethnopharmacology (2025), pp. 119514-119514
Closed Access
Metabolic insights into gut microbiota in the pharmacology of natural medicines
Zixin Chen, Junchi Zhou, Xiao Zheng, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 2, pp. 158-168
Closed Access
Alpha-aminobutyric Acid Ameliorates Diet-induced Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression in Mice via Enhancing AMPK/SIRT1 Pathway and Modulating the Gut-Liver Axis
Felicianna, Emily Kwun Kwan Lo, Congjia Chen, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109885-109885
Open Access
Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet‐Induced Non‐Alcoholic Steatohepatitis (NASH) Mice
Chuhong Su, Jiexian Wang, Huiyu Luo, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 3
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier
Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118649-118649
Closed Access | Times Cited: 3
Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways
Jiahua Wang, Juan Zang, Yu Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Saikosaponin a ameliorates diet-induced fatty liver via regulating intestinal microbiota and bile acid profile in laying hens
Jia Feng, Hui Ma, Yanrui Yue, et al.
Poultry Science (2023) Vol. 102, Iss. 12, pp. 103155-103155
Open Access | Times Cited: 8
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 11
Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study
Wenjing Huang, Jiuyuan Wang, Min Kuang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6
The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications
Zichen Luo, Wei Zhou, Tong Xie, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3385-3415
Open Access | Times Cited: 1
Astragaloside IV Ameliorates Colonic Adenomatous Polyps Development by Orchestrating Gut Bifidobacterium and Serum Metabolome
Luping Wen, Shaowei Gao, Huaxian Chen, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 05, pp. 1527-1554
Closed Access | Times Cited: 1
The Impact of a Natural Ingredients based Intervention Targeting the Nine Hallmarks of Aging on DNA methylation
Natàlia Carreras-Gallo, Rita Dargham, Shealee Thorpe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lipidomics reveals the lipid-lowering and hepatoprotective effects of Celosia Semen on high-fat diet-induced NAFLD mice
Jin‐Quan Zhao, Zhou Qiqi, Ke Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118922-118922
Closed Access | Times Cited: 1
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sevag Hamamah, Oana C. Iatcu, Mihai Covașă
Nutrients (2024) Vol. 17, Iss. 1, pp. 143-143
Open Access | Times Cited: 1
Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver disease
Bao Yang, Xiao Han, Da Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Simiao Wan attenuates high-fat diet-induced hyperlipidemia in mice by modulating the gut microbiota–bile acid axis
Kexin Wang, Wenjie Xu, Wen He, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118868-118868
Closed Access
Loureirin B Ameliorates Glycolipid Metabolism Disorders in Ob/ob Mice by Regulating Bile Acid Levels and Modulating Gut Microbiota Composition
Junyang Zhang, Xiaoyan Zhang, Gen Li, et al.
Chemistry & Biodiversity (2024)
Open Access
Astragaloside IV alleviates diabetic nephropathy by modulating the kidney-gut axis AMPK/PI3K/AKT pathway
Pin Gong, Hui Long, Qian Yang, et al.
Food Bioscience (2024) Vol. 62, pp. 105448-105448
Closed Access
Regulation of bile acids and their receptor FXR in metabolic diseases
Yao Li, Lulu Wang, Yi Qing, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Polysaccharide from Angelica sinensis with medicinal and edible purposes ameliorated NAFLD by the bile acids mediated activation of FXR
Weiliang Chen, Li Luo, Jun Xiang, et al.
Food Science and Technology (2023) Vol. 43
Open Access
Page 1

Scroll to top